- Home
- KE vs SVRA Comparison
KE vs SVRA Comparison
Compare KE & SVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KE
- SVRA
- Stock Information
- Founded
- KE 1961
- SVRA 2007
- Country
- KE United States
- SVRA United States
- Employees
- KE N/A
- SVRA N/A
- Industry
- KE Electrical Products
- SVRA Biotechnology: Pharmaceutical Preparations
- Sector
- KE Technology
- SVRA Health Care
- Exchange
- KE Nasdaq
- SVRA Nasdaq
- Market Cap
- KE 459.3M
- SVRA 527.2M
- IPO Year
- KE N/A
- SVRA N/A
- Fundamental
- Price
- KE $30.30
- SVRA $3.57
- Analyst Decision
- KE Strong Buy
- SVRA Buy
- Analyst Count
- KE 1
- SVRA 8
- Target Price
- KE $28.00
- SVRA $6.63
- AVG Volume (30 Days)
- KE 331.5K
- SVRA 1.9M
- Earning Date
- KE 11-03-2025
- SVRA 08-13-2025
- Dividend Yield
- KE N/A
- SVRA N/A
- EPS Growth
- KE N/A
- SVRA N/A
- EPS
- KE 0.68
- SVRA N/A
- Revenue
- KE $1,486,727,000.00
- SVRA N/A
- Revenue This Year
- KE N/A
- SVRA N/A
- Revenue Next Year
- KE $4.02
- SVRA N/A
- P/E Ratio
- KE $45.06
- SVRA N/A
- Revenue Growth
- KE N/A
- SVRA N/A
- 52 Week Low
- KE $12.41
- SVRA $1.89
- 52 Week High
- KE $30.85
- SVRA $4.70
- Technical
- Relative Strength Index (RSI)
- KE 78.29
- SVRA 64.79
- Support Level
- KE $29.40
- SVRA $3.70
- Resistance Level
- KE $30.85
- SVRA $3.92
- Average True Range (ATR)
- KE 0.82
- SVRA 0.18
- MACD
- KE -0.12
- SVRA 0.01
- Stochastic Oscillator
- KE 86.89
- SVRA 56.06
About KE Kimball Electronics Inc.
Kimball Electronics Inc is a contract electronic manufacturing services company. The company is engaged in producing durable electronics for the automotive, medical, industrial, and public safety end markets. The company's engineering, manufacturing, and supply chain services utilize common production and support capabilities. It is also engaged in producing safety-critical electronic assemblies for its automotive customers. Geographically, it has business units located in the United States, China, Mexico, Poland, Romania, and Thailand. The company derives maximum revenue from Mexico.
About SVRA Savara Inc.
Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.